Being obese is not fun; they don’t eat or do some activities like normal people. Obese men and women are looking for a medication that could help them lose weight quickly and maintain their weight over a long period. There are several pills to slim down, but lorcaserin is one of those weight loss pills to get approved from FDA in 2012. Lorcaserin is truly a new compound in over a decade. Lorcaserin is different from other pills. Patients take this pill, and they feel good about taking it. It’s a really well-tolerated compound that makes it possible to drop a lot of weight. The pill loses two-third of the patients; they lose at least five percent of their body weight.
The average weight of that group is 26 pounds, and this is exactly what doctors want. Moreover, of course, to losing weight, there’s an improvement in their cardiometabolic parameters like blood pressure goes down, heart rate goes down, cholesterol goes down, everything goes in the right direction, and that’s what physicians are excited about. Lorcaserin reduces a patient’s appetite and block fat from being absorbed. Additionally, it keeps the patient’s metabolism. So, patients typically lose weight very frequently.
Lorcaserin has the capacity to do a billion-plus in sales. Two-thirds of adults may benefit from losing some weight. In America, a third is obese. Obesity is an important contribution to things like diabetics and cardiovascular disease. The majority of the patients can use Lorcaserin to lose weight quickly and keep that weight very long.
Lorcaserin has the opportunity to alter the way obesity is treated around the world. Investors have started to recognize that there are safe and effective drugs for weight reduction. It benefits from weight loss and the other things you want to accomplish from weight loss, such as good cholesterol and insulin resistance reduction. Together with the pill, potency comes a negative effect such as vomiting, dizziness, diarrhea, fatigue, headache, etc.. But, the majority of the weight loss pills have the same side effect.
Lorcaserin increased any risk of cardiovascular complications such as chest pain, heart attack, etc.; for those taking the medication, don’t freak up just yet. The FDA has not made any definite conclusion. There are countless people on the planet, so 1 trial of twelve million people isn’t enough. However, you do have to think about this information. With this new possibility of increased cancer risk, you need to ask yourself if the benefit of therapy still reduces the risk. It is what the health care and you will need to determine before continuing treatment with lorcaserin.